Providence Health Service System, AD Center, Brain Institute — Portland, Oregon

Providence Health Service System, AD Center, Brain Institute is a clinical research site located in Portland, Oregon, United States 97225.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Providence Health Service System, AD Center, Brain Institute has participated in 3 clinical trials.

Therapeutic areas: Alzheimer's Disease.

Sponsors: JANSSEN Alzheimer Immunotherapy Research & Development, LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Portland

Browse all research sites in Oregon · View every site in Portland

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Providence Health Service System, AD Center, Brain Institute?

Providence Health Service System, AD Center, Brain Institute has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Providence Health Service System, AD Center, Brain Institute conducted?

Providence Health Service System, AD Center, Brain Institute has 3 clinical trials on record. Their work covers Alzheimer's Disease.

Is Providence Health Service System, AD Center, Brain Institute accredited by Crixeo Clinical Trials?

Providence Health Service System, AD Center, Brain Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Providence Health Service System, AD Center, Brain Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.